MapLight Therapeutics, Inc. MPLT 深 沪
等待开盘 08-10 09:30:00 美东时间
12.17
-1.110
-8.36%
华盛通- 最 高13.74
- 今 开13.28
- 成交量 41.60万股
- 最 低 12.09
- 昨 收 13.28
- 总市值 0
- 52周最高 40.43
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 9.10
- 委 比 -52.44%
- 总股本 --
- 历史最高 40.43
- 量 比 0
- 振 幅 12.42%
- 历史最低 9.10
- 每 手 1
- 风险率 7.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MapLight Therapeutics Stock Falls Despite Schizophrenia Drug Meeting Main Trial Goal
MapLight says Phase 2 schizophrenia data showed strong twice-daily efficacy while the once-daily dose missed the primary endpoint.
07-28 00:00
MapLight's Psychosis Drug Could Deliver Billion-Dollar Upside, Says Analyst
Needham initiates MapLight with Buy, citing ML-007C-MA potential in schizophrenia and AD psychosis, with key readouts expected through 2027.
04-09 02:29
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
MapLight Therapeutics Q3 EPS $(37.18) Misses $(1.55) Estimate
MapLight Therapeutics (NASDAQ:MPLT) reported quarterly losses of $(37.18) per share which missed the analyst consensus estimate of $(1.55) by 2291 percent. This is a 48.25 percent decrease over losses of $(25.08) per
2025-12-04 21:06
